Table 3 Baseline demographic and clinical characteristics of the study participants with cyst sizes ≥ 10 cm and < 10 cm
Variables | Size ≥ 10 cm | Size < 10 cm | ||||
|---|---|---|---|---|---|---|
TU-LESS (n = 52) | MLS (n = 58) | P | TU-LESS(n = 184) | MLS (n = 234) | P | |
Symptom | 4.00 ± 1.80 | 4.00 ± 2.00 | 0.70 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.36 |
CA125 | 19.86 ± 7.22 | 18.01 ± 7.90 | 0.68 | 14.80 ± 4.35 | 14.80 ± 4.25 | 0.44 |
HE4 | 63.94 ± 37.07 | 59.52 ± 30.51 | 0.10 | 44.55 ± 33.15 | 42.30 ± 37.10 | 0.64 |
Age | 25.50 ± 37.00 | 33.00 ± 40.00 | 0.43 | 40.00 ± 19.00 | 37.00 ± 20.00 | 0.14 |
Unilateral | 37 (71.29%) | 48 (82.8%) | 0.15 | 164(89.1%) | 196(83.8%) | 0.12 |
Bilateral | 15 (82.8%) | 10 (17.2%) | 20(10.9%) | 38 (16.2%) | ||
Procedure | ||||||
Unilateral salpingo oophorectomy | 2 (3.8%) | 1 (1.7%) | 0.44 | 27 (14.7%) | 21 (9.0%) | 0.27 |
Unilateral ovarian cystectomy | 27(51.9%) | 35 (60.3%) | 111 (60.3%) | 145 (62.0%) | ||
Bilateral salpingo oophorectomy | 16 (30.8%) | 19 (32.8%) | 27 (14.7%) | 36 (15.4%) | ||
Bilateral ovarian cystectomy | 7 (13.5%) | 3 (5.2%) | 19 (10.3%) | 32 (13.7%) | ||
History | ||||||
Yes | 8 (15.4%) | 11 (19.0%) | 0.62 | 146 (79.3%) | 185 (79.1%) | 0.94 |
No | 44 (84.6%) | 47 (81.0%) | 38 (20.7%) | 49 (20.9%) | ||
Pathology | ||||||
Serouscystadeno-ma | 21(40.4%) | 27 (46.6%) | 0.91 | 78 (42.4%) | 87 (37.2%) | 0.21 |
Mucinouscystaden-oma | 16 (30.8%) | 18 (31.0%) | 36 (19.6%) | 45 (19.2%) | ||
Mature cystic teratoma | 9 (17.3%) | 9 (15.5%) | 38 (20.7%) | 47 (20.1%) | ||
Endometrioma | 4 (7.7%) | 3 (5.2%) | 17 (9.2%) | 40 (17.1%) | ||
Paroophoritic cyst | 2 (3.8%) | 1 (1.7%) | 15 (8.2%) | 15 (6.4%) | ||
BMI, kg/m2 | 23.34 ± 3.38 | 23.48 ± 4.22 | 0.00 | 23.00 ± 4.38 | 24.00 ± 3.53 | 0.94 |